<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36560633</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>12</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>25</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Long-COVID Symptoms in Individuals Infected with Different SARS-CoV-2 Variants of Concern: A Systematic Review of the Literature.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2629</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v14122629</ELocationID><Abstract><AbstractText>The association of SARS-CoV-2 variants with long-COVID symptoms is still scarce, but new data are appearing at a fast pace. This systematic review compares the prevalence of long-COVID symptoms according to relevant SARS-CoV-2 variants in COVID-19 survivors. The MEDLINE, CINAHL, PubMed, EMBASE and Web of Science databases, as well as the medRxiv and bioRxiv preprint servers, were searched up to 25 October 2022. Case-control and cohort studies analyzing the presence of post-COVID symptoms appearing after an acute SARS-CoV-2 infection by the Alpha (B.1.1.7), Delta (B.1.617.2) or Omicron (B.1.1.529/BA.1) variants were included. Methodological quality was assessed using the Newcastle-Ottawa Scale. From 430 studies identified, 5 peer-reviewed studies and 1 preprint met the inclusion criteria. The sample included 355 patients infected with the historical variant, 512 infected with the Alpha variant, 41,563 infected with the Delta variant, and 57,616 infected with the Omicron variant. The methodological quality of all studies was high. The prevalence of long-COVID was higher in individuals infected with the historical variant (50%) compared to those infected with the Alpha, Delta or Omicron variants. It seems that the prevalence of long-COVID in individuals infected with the Omicron variant is the smallest, but current data are heterogeneous, and long-term data have, at this stage, an obviously shorter follow-up compared with the earlier variants. Fatigue is the most prevalent long-COVID symptom in all SARS-CoV-2 variants, but pain is likewise prevalent. The available data suggest that the infection with the Omicron variant results in fewer long-COVID symptoms compared to previous variants; however, the small number of studies and the lack of the control of cofounders, e.g., reinfections or vaccine status, in some studies limit the generality of the results. It appears that individuals infected with the historical variant are more likely to develop long-COVID symptomatology.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-de-Las-Pe&#xf1;as</LastName><ForeName>C&#xe9;sar</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3772-9690</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos, 28933 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Science and Technology, Faculty of Medicine, Center for Neuroplasticity and Pain (CNAP), Sensory Motor Interaction (SMI), Aalborg University, 9220 Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Notarte</LastName><ForeName>Kin Israel</ForeName><Initials>KI</Initials><Identifier Source="ORCID">0000-0002-6055-0886</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peligro</LastName><ForeName>Princess Juneire</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Surgery, University of Santo Tomas, Manila 1008, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Velasco</LastName><ForeName>Jacqueline Veronica</ForeName><Initials>JV</Initials><Identifier Source="ORCID">0000-0001-7028-8175</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine and Surgery, University of Santo Tomas, Manila 1008, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ocampo</LastName><ForeName>Miguel Joaqu&#xed;n</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Surgery, University of Santo Tomas, Manila 1008, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henry</LastName><ForeName>Brandon Michael</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Clinical Laboratory, Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arendt-Nielsen</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Health Science and Technology, Faculty of Medicine, Center for Neuroplasticity and Pain (CNAP), Sensory Motor Interaction (SMI), Aalborg University, 9220 Aalborg, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Gastroenterology, Mech-Sense, Aalborg University Hospital, 9000 Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres-Macho</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Hospital Universitario Infanta Leonor-Virgen de la Torre, 28031 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, School of Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plaza-Manzano</LastName><ForeName>Gustavo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-1596-5027</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, Universidad Complutense de Madrid, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Wuhan</Keyword><Keyword MajorTopicYN="N">alpha</Keyword><Keyword MajorTopicYN="N">delta</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">post-COVID-19</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>23</Day><Hour>2</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36560633</ArticleId><ArticleId IdType="pmc">PMC9785120</ArticleId><ArticleId IdType="doi">10.3390/v14122629</ArticleId><ArticleId IdType="pii">v14122629</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Parra-Lucares A., Segura P., Rojas V., Pumarino C., Saint-Pierre G., Toro L. Emergence of SARS-CoV-2 variants in the world: How could this happen? Life. 2022;12:194. doi: 10.3390/life12020194.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12020194</ArticleId><ArticleId IdType="pmc">PMC8879166</ArticleId><ArticleId IdType="pubmed">35207482</ArticleId></ArticleIdList></Reference><Reference><Citation>Thye A.Y., Law J.W., Pusparajah P., Letchumanan V., Chan K.G., Lee L.H. Emerging SARS-CoV-2 Variants of Concern (VOCs): An Impending Global Crisis. Biomedicines. 2021;9:1303. doi: 10.3390/biomedicines9101303.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9101303</ArticleId><ArticleId IdType="pmc">PMC8533361</ArticleId><ArticleId IdType="pubmed">34680420</ArticleId></ArticleIdList></Reference><Reference><Citation>Tani-Sassa C., Iwasaki Y., Ichimura N., Nagano K., Takatsuki Y., Yuasa S., Takahashi Y., Nakajima J., Sonobe K., Nukui Y., et al. Viral loads and profile of the patients infected with SARS-CoV-2 Delta, Alpha, or R.1 variants in Tokyo. J. Med. Virol. 2022;94:1707&#x2013;1710. doi: 10.1002/jmv.27479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27479</ArticleId><ArticleId IdType="pmc">PMC9015476</ArticleId><ArticleId IdType="pubmed">34825717</ArticleId></ArticleIdList></Reference><Reference><Citation>Teyssou E., Delagr&#xe8;verie H., Visseaux B., Lambert-Niclot S., Brichler S., Ferre V., Marot S., Jary A., Todesco E., Schnuriger A., et al. The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients. J. Infect. 2021;83:e1&#x2013;e3. doi: 10.1016/j.jinf.2021.08.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.08.027</ArticleId><ArticleId IdType="pmc">PMC8375250</ArticleId><ArticleId IdType="pubmed">34419559</ArticleId></ArticleIdList></Reference><Reference><Citation>Karim S.S.A., Karim Q.A. Omicron SARS-CoV-2 variant: A new chapter in the COVID-19 pandemic. Lancet. 2021;398:2126&#x2013;2128. doi: 10.1016/S0140-6736(21)02758-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02758-6</ArticleId><ArticleId IdType="pmc">PMC8640673</ArticleId><ArticleId IdType="pubmed">34871545</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoang V.T., Colson P., Levasseur A., Delerce J., Lagier J.C., Parola P., Million M., Fournier P.E., Raoult D., Gautret P. Clinical outcomes in patients infected with different SARS-CoV-2 variants at one hospital during three phases of the COVID-19 epidemic in Marseille, France. Infect Genet. Evol. 2021;95:105092. doi: 10.1016/j.meegid.2021.105092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2021.105092</ArticleId><ArticleId IdType="pmc">PMC8462069</ArticleId><ArticleId IdType="pubmed">34571275</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S., Lim S.Y., Kim J.Y., Park H., Lim J.S., Bae S., Kim J., Jung J., Kim M.J., Chong Y.P., et al. Clinical and virological characteristics of SARS-CoV-2 B.1.617.2 (Delta) variant: A prospective cohort study. Clin. Infect. Dis. 2022;75:e27&#x2013;e34. doi: 10.1093/cid/ciac239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac239</ArticleId><ArticleId IdType="pmc">PMC9047158</ArticleId><ArticleId IdType="pubmed">35362530</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C. Long COVID: Current definition. Infection. 2022;50:285&#x2013;286. doi: 10.1007/s15010-021-01696-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01696-5</ArticleId><ArticleId IdType="pmc">PMC8438555</ArticleId><ArticleId IdType="pubmed">34519974</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V., WHO Clinical Case Definition Working Group on Post-COVID-19 Condition A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Palacios-Ce&#xf1;a D., G&#xf3;mez-Mayordomo V., Florencio L.L., Cuadrado M.L., Plaza-Manzano G., Navarro-Santana M. Prevalence of Post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Eur. J. Int. Med. 2021;92:55&#x2013;70. doi: 10.1016/j.ejim.2021.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q., Zheng B., Daines L., Sheikh A. Long-term sequelae of COVID-19: A systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. 2022;11:269. doi: 10.3390/pathogens11020269.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global prevalence of post COVID-19 condition or long COVID: A meta-analysis and systematic review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P., Patel K., Pinto C., Jaiswal R., Tirupathi R., Pillai S., Patel U. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)&#x2014;A systematic review and meta-analysis. J. Med. Virol. 2022;94:253&#x2013;262. doi: 10.1002/jmv.27309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27309</ArticleId><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise J. COVID-19: Two million people in the UK are estimated to be experiencing long COVID, says ONS. BMJ. 2022;377:o1391. doi: 10.1136/bmj.o1391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o1391</ArticleId><ArticleId IdType="pubmed">35649534</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson C. Long COVID risk with omicron may be half that of delta. New Sci. 2022;254:12. doi: 10.1016/S0262-4079(22)01099-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0262-4079(22)01099-5</ArticleId><ArticleId IdType="pmc">PMC9232251</ArticleId><ArticleId IdType="pubmed">35782298</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise J. COVID-19: Long COVID risk is lower with omicron than delta, researchers find. BMJ. 2022;377:o1500. doi: 10.1136/bmj.o1500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o1500</ArticleId><ArticleId IdType="pubmed">35714995</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward H., Flower B., Garcia P.J., Ong S.W.X., Altmann D.M., Delaney B., Smith N., Elliott P., Cooke G. Global surveillance, research, and collaboration needed to improve understanding and management of long COVID. Lancet. 2021;398:2057&#x2013;2059. doi: 10.1016/S0140-6736(21)02444-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02444-2</ArticleId><ArticleId IdType="pmc">PMC8580495</ArticleId><ArticleId IdType="pubmed">34774190</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long COVID: Mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Maglietta G., Diodati F., Puntoni M., Lazzarelli S., Marcomini B., Patrizi L., Caminiti C. Prognostic factors for post-COVID-19 syndrome: A systematic review and meta-analysis. J. Clin. Med. 2022;11:1541. doi: 10.3390/jcm11061541.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11061541</ArticleId><ArticleId IdType="pmc">PMC8948827</ArticleId><ArticleId IdType="pubmed">35329867</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P., Liu J., Liu M. Effect of COVID-19 vaccines on reducing the risk of long COVID in the real world: A systematic review and meta-analysis. Int. J. Environ. Res. Public Health. 2022;19:12422. doi: 10.3390/ijerph191912422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912422</ArticleId><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E., et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372:n7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G.A., Tugwell P., O&#x2019;Connell D., Welch V., Peterson J., Shea B. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. 2015.</Citation></Reference><Reference><Citation>Antonelli M., Pujol J.C., Spector T.D., Ourselin S., Steves C.J. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Morioka S., Tsuzuki S., Suzuki M., Terada M., Akashi M., Osanai Y., Kuge C., Sanada M., Tanaka K., Maruki T., et al. Post COVID-19 condition of the Omicron variant of SARS-CoV-2. J. Infect. Chemother. 2022;28:1546&#x2013;1551. doi: 10.1016/j.jiac.2022.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiac.2022.08.007</ArticleId><ArticleId IdType="pmc">PMC9365517</ArticleId><ArticleId IdType="pubmed">35963600</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini E., Levi R., Sarti R., Pozzi C., Mollura M., Mantovani A., Rescigno M. Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers. JAMA. 2022;328:676&#x2013;678. doi: 10.1001/jama.2022.11691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.11691</ArticleId><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Cancela-Cilleruelo I., Rodr&#xed;guez-Jim&#xe9;nez J., G&#xf3;mez-Mayordomo V., Pellicer-Valero O.J., Mart&#xed;n-Guerrero J.D., Hern&#xe1;ndez-Barrera V., Arendt-Nielsen L., Torres-Macho J. Associated-onset symptoms and post-COVID-19 symptoms in hospitalized COVID-19 survivors infected with Wuhan, Alpha or Delta SARS-CoV-2 variant. Pathogens. 2022;11:725. doi: 10.3390/pathogens11070725.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11070725</ArticleId><ArticleId IdType="pmc">PMC9320021</ArticleId><ArticleId IdType="pubmed">35889971</ArticleId></ArticleIdList></Reference><Reference><Citation>Arjun M.C., Singh A.K., Roy P., Ravichandran M., Mandal S., Pal D., Das K., Alekhya G., Venkateshan M., Mishra B., et al. Long COVID following Omicron wave in Eastern India&#x2014;A retrospective cohort study. J. Med. Virol. 2022 doi: 10.1002/jmv.28214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28214</ArticleId><ArticleId IdType="pmc">PMC9874641</ArticleId><ArticleId IdType="pubmed">36224705</ArticleId></ArticleIdList></Reference><Reference><Citation>Qasmieh S.A., Robertson M.M., Teasdale C.A., Kulkarni S.G., Jones H., McNairy M., Borrell L.N., Nash D. The prevalence of SARS-CoV-2 infection and long COVID in US adults during the BA.5 surge, June&#x2013;July 2022. medRxiv. 2022 doi: 10.1101/2022.09.04.22279588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.09.04.22279588</ArticleId><ArticleId IdType="pmc">PMC9940463</ArticleId><ArticleId IdType="pubmed">36813250</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE) Royal College of General Practitioners. Healthcare Improvement Scotland SIGN  . COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. National Institute for Health and Care Excellence; London, UK: 2020.  [(accessed on 30 October 2022)].  Available online:  www.nice.org.uk/guidance/ng188.</Citation></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Rodr&#xed;guez-Jim&#xe9;nez J., Cancela-Cilleruelo I., Guerrero-Peral A., Mart&#xed;n-Guerrero J.D., Garc&#xed;a-Azor&#xed;n D., Cornejo-Mazzuchelli A., Hern&#xe1;ndez-Barrera V., Pellicer-Valero O.J. Post-COVID-19 symptoms 2 years after SARS-CoV-2 infection among hospitalized vs non-hospitalized patients. JAMA Netw. Open. 2022;5:e2242106. doi: 10.1001/jamanetworkopen.2022.42106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.42106</ArticleId><ArticleId IdType="pmc">PMC9667330</ArticleId><ArticleId IdType="pubmed">36378309</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Sullivan O. Long-term sequelae following previous coronavirus epidemics. Clin. Med. 2021;21:e68&#x2013;e70. doi: 10.7861/clinmed.2020-0204.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0204</ArticleId><ArticleId IdType="pmc">PMC7850177</ArticleId><ArticleId IdType="pubmed">33144403</ArticleId></ArticleIdList></Reference><Reference><Citation>Menges D., Ballouz T., Anagnostopoulos A., Aschmann H.E., Domenghino A., Fehr J.S., Puhan M.A. Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study. PLoS ONE. 2021;16:e0254523. doi: 10.1371/journal.pone.0254523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254523</ArticleId><ArticleId IdType="pmc">PMC8274847</ArticleId><ArticleId IdType="pubmed">34252157</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Mart&#xed;n-Guerrero J.D., Cancela-Cilleruelo I., Moro-L&#xf3;pez-Menchero P., Pellicer-Valero O.J. Exploring the recovery curve for long-term post-COVID dyspnea and fatigue. Eur. J. Intern Med. 2022;101:120&#x2013;123. doi: 10.1016/j.ejim.2022.03.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2022.03.036</ArticleId><ArticleId IdType="pmc">PMC9046058</ArticleId><ArticleId IdType="pubmed">35490087</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay A. A paradigm for post-COVID-19 fatigue syndrome analogous to ME/CFS. Front. Neurol. 2021;12:701419. doi: 10.3389/fneur.2021.701419.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.701419</ArticleId><ArticleId IdType="pmc">PMC8365156</ArticleId><ArticleId IdType="pubmed">34408721</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffke M., Freitag H., Rudolf G., Seifert M., Doehner W., Scherbakov N., Hanitsch L., Wittke K., Bauer S., Konietschke F., et al. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) J. Transl. Med. 2022;20:138. doi: 10.1186/s12967-022-03346-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03346-2</ArticleId><ArticleId IdType="pmc">PMC8938726</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigal A. Milder disease with Omicron: Is it the virus or the pre-existing immunity? Nat. Rev. Immunol. 2022;22:69&#x2013;71. doi: 10.1038/s41577-022-00678-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00678-4</ArticleId><ArticleId IdType="pmc">PMC8767774</ArticleId><ArticleId IdType="pubmed">35046570</ArticleId></ArticleIdList></Reference><Reference><Citation>Sette A., Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell. 2021;184:861&#x2013;880. doi: 10.1016/j.cell.2021.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.01.007</ArticleId><ArticleId IdType="pmc">PMC7803150</ArticleId><ArticleId IdType="pubmed">33497610</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G., Nocini R., Henry B.M. Analysis of online search trends suggests that SARS-CoV-2 Omicron (B.1.1.529) variant causes different symptoms. J. Infect. 2022;84:e76&#x2013;e77. doi: 10.1016/j.jinf.2022.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.02.011</ArticleId><ArticleId IdType="pmc">PMC8851877</ArticleId><ArticleId IdType="pubmed">35183609</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahra S.A., Iddawela S., Pillai K., Choudhury R.Y., Harky A. Can symptoms of anosmia and dysgeusia be diagnostic for COVID-19? Brain Behav. 2020;10:e01839. doi: 10.1002/brb3.1839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.1839</ArticleId><ArticleId IdType="pmc">PMC7667367</ArticleId><ArticleId IdType="pubmed">32935915</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD)  [(accessed on 15 October 2022)]; Available online:  https://www.cdc.gov/flu/symptoms/flu-vs-covid19.htm.</Citation></Reference><Reference><Citation>Notarte K.I., Catahay J.A., Velasco J.V., Pastrana A., Ver A.T., Pangilinan F.C., Peligro P.J., Casimiro M., Guerrero J.J., Gellaco M.M.L., et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. EClinicalMedicine. 2022;53:101624. doi: 10.1016/j.eclinm.2022.101624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Penetra S.L.S., da Silva M.F.B., Resende P., Pina-Costa A., Santos H.F.P., Guaraldo L., Calvet G.A., Ogrzewalska M., Arantes I., Zukeram K., et al. Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil. Int. J. Infect. Dis. 2022;114:58&#x2013;61. doi: 10.1016/j.ijid.2021.10.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.10.048</ArticleId><ArticleId IdType="pmc">PMC8553653</ArticleId><ArticleId IdType="pubmed">34757006</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo C.K., Mertz D., Loeb M. Newcastle-Ottawa Scale: Comparing reviewers&#x2019; to authors&#x2019; assessments. BMC Med. Res. Methodol. 2014;14:45. doi: 10.1186/1471-2288-14-45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-45</ArticleId><ArticleId IdType="pmc">PMC4021422</ArticleId><ArticleId IdType="pubmed">24690082</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V.T., Riveros C., Clepier B., Desvarieux M., Collet C., Yordanov Y., Ravaud P. Development and validation of the long COVID symptom and impact tools, a set of patient-reported instruments constructed from patients&#x2019; lived experience. Clin. Infect. Dis. 2022;74:278&#x2013;287. doi: 10.1093/cid/ciab352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab352</ArticleId><ArticleId IdType="pmc">PMC8135558</ArticleId><ArticleId IdType="pubmed">33912905</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>